SAN FRANCISCO (GenomeWeb News) – A pair of large, international consortia are cranking out reams of genome, exome, and genotyping data in the hopes of expanding and refining their understanding of the genetic factors behind type 2 diabetes and traits related to it.

Each of the groups provided information on the strategies they are using to reach that goal — and the progress made so far — in several talks and posters presented at the American Society of Human Genetics annual meeting held here last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.